about
Identification of a lysosomal peptide transport system induced during dendritic cell developmentThe bacterial preparation OK432 induces IL-12p70 secretion in human dendritic cells in a TLR3 dependent mannerEpithelial-specific transcription factor ESE-3 is involved in the development of monocyte-derived DCs.Maturation of monocyte derived dendritic cells with OK432 boosts IL-12p70 secretion and conveys strong T-cell responses.Identification and localization of a new human myotubularin-related protein gene, mtmr8, on 8p22-p23.Physical and transcriptional map of the critical region for keratolytic winter erythema (KWE) on chromosome 8p22-p23 between D8S550 and D8S1759.Association of EBF1, FAM167A(C8orf13)-BLK and TNFSF4 gene variants with primary Sjögren's syndrome.The complexity of Sjögren's syndrome: novel aspects on pathogenesis.Expression of ESE-3 isoforms in immunogenic and tolerogenic human monocyte-derived dendritic cells.Altered phenotype and Stat1 expression in Toll-like receptor 7/8 stimulated monocyte-derived dendritic cells from patients with primary Sjögren's syndrome.Expression of Toll-like receptor -7 and -9 in B cell subsets from patients with primary Sjögren's syndrome.Effect of tyrosine kinase inhibition using imatinib on normal lymphohematopoietic cells.Effects of imatinib on normal hematopoiesis and immune activation.New concepts in the pathogenesis of Sjögren's syndrome.In vitro suppression of immune responses using monocyte-derived tolerogenic dendritic cells from patients with primary Sjögren's syndrome.Current status and future perspectives of dendritic cell-based cancer immunotherapy.Characterization of monocyte-derived dendritic cells from immunosuppressed renal transplant recipients with and without squamous cell carcinomas.Induction of adipophilin-specific cytotoxic T lymphocytes using a novel HLA-A2-binding peptide that mediates tumor cell lysis.Imatinib mesylate affects the development and function of dendritic cells generated from CD34+ peripheral blood progenitor cells.Processing and presentation of HLA class I and II epitopes by dendritic cells after transfection with in vitro-transcribed MUC1 RNA.Reply to 'comment on no association of primary Sjögren's syndrome with Fcγ receptor gene variants'.Severe impairment of dendritic cell allostimulatory activity by Sendai virus vectors is overcome by matrix protein gene deletion.No association of primary Sjögren's syndrome with Fcγ receptor gene variants.Effects of imatinib on monocyte-derived dendritic cells are mediated by inhibition of nuclear factor-kappaB and Akt signaling pathways.PPAR-gamma agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-kappaB pathways.Patients with Primary Sjögren's Syndrome Have Alterations in Absolute Quantities of Specific Peripheral Leucocyte Populations.Phosphorylation of intracellular signaling molecules in peripheral blood cells from psoriasis patients on originator or biosimilar infliximab.TLR-7 and -9 Stimulation of Peripheral Blood B Cells Indicate Altered TLR Signalling in Primary Sjögren's Syndrome Patients by Increased Secretion of Cytokines.Aberrant cell signalling in PBMCs upon IFN-α stimulation in primary Sjögren's syndrome patients associates with type I interferon signature.Peritumoral dermis of squamous cell carcinomas in renal transplant recipients contains less CD11c+ myeloid dendritic cells and FoxP3+ T cells compared to immunocompetent controls.Effective polyethylene glycol passivation for the inhibition of surface interactions of peripheral blood mononuclear cells and platelets.Transfection of dendritic cells with in vitro-transcribed CMV RNA induces polyclonal CD8+- and CD4+-mediated CMV-specific T cell responses.Differential regulation of MHC II and invariant chain expression during maturation of monocyte-derived dendritic cells.Potential association of muscarinic receptor 3 gene variants with primary Sjogren's syndromeSurface-Mediated Priming DuringIn VitroGeneration of Monocyte-Derived Dendritic CellsCD11c+ Dendritic Cells Rather than Langerhans Cells are Reduced in Normal Skin of Immunosuppressed Renal Transplant RecipientsActivation of Peroxisome Proliferator-activated Receptor Gamma Leads to Upregulation of ESE-3 Expression in Human Monocyte-derived Dendritic CellsType 1 Regulatory T Cells and Regulatory B Cells Induced by Tolerogenic Dendritic CellsQuantification of Plasmacytoid Dendritic Cells and Type 1 Myeloid Dendritic Cells in Peripheral Blood of Renal Transplant Recipients With and Without Squamous Cell CarcinomaAnti-Ro and anti-La autoantibody profiling in Norwegian patients with primary Sjögren’s syndrome using luciferase immunoprecipitation systems (LIPS)
P50
Q24299256-A54BD4CB-3ED5-4112-BDF6-495B7031DCE9Q28480997-3E2CF2DB-D26E-4095-85D1-3E5E9DA1CC27Q33230388-11225509-6735-4D9E-8C13-D494A44971E6Q33786246-1C037584-4E9C-4B5F-BC20-1E18D2704D13Q34085008-FD07F883-3AC6-4A5B-9782-930E28BB8DDEQ34118711-814FA91A-220B-4BEC-B38E-57B07FA97D3FQ34139580-56ECA948-772F-462C-9CE4-A1C879C22395Q34202426-2FF31DC0-053E-4D02-AEF5-35AEADBA30A7Q34490196-91691A01-C403-467C-9866-59D622FFC237Q34669630-65D680E2-F1AD-4488-AB84-EF6A38F620EFQ35196207-11B4C78B-89DF-44F4-AB73-8F23EADA174EQ36164524-AE762899-70D0-48A8-84EB-C62144A3BC9AQ36248539-C426BE9B-1639-475E-8613-2588C43DA0A8Q37317544-E4295234-99D2-4318-872A-44FDFB5557B7Q37689751-DE3B8CC0-ED9B-4C9D-A394-7712CD2C61C3Q38106733-4F20CC79-53BA-467C-AF14-A577504FE51DQ39398806-38F461BA-DDA3-4229-A01A-F547E4D3A666Q40590724-1C67C14B-60C4-4B53-9B49-9BB7AEC1F1D8Q44592666-7CC61AE2-1F23-419E-86C6-6E11729CC3BFQ45200866-01D75D2D-E24A-4712-A38B-4E6EE76A5EAEQ45239026-B900CCE6-9AD9-4E17-B58A-A6F976D86E2EQ45423458-AC2E4867-1B4E-4065-ACF2-8C02D0C2032DQ46093255-1861AF60-2C92-4E60-A7FA-0D837F730769Q46365793-B77C0033-E6BC-49E8-86BD-8E405C7FDE04Q46655077-6BEB4875-CB46-4ED8-B0B1-5829C596F7C6Q47601511-86D9D69C-2A4F-45AE-98B9-635A94A71321Q49602594-CBAA876E-13F7-4E89-B724-1DFAC8824DA3Q50711764-11FF29E3-9787-4656-9C69-C07EB5130086Q52336160-D737990E-94B7-4C3F-9150-5FC19A0E6E30Q53556283-E9414C2F-E5DB-4261-866A-E9C5A9FC0298Q54279653-563DFC39-B696-4536-9173-12B88D7C8151Q54321271-F2F35934-B1BD-453D-A62D-0D97FDE87484Q54321603-D5C21E4E-BCE2-4B3E-8A70-EF4ABA141D95Q57410897-CE39B34E-5A16-4FA2-85C5-17B37A71861CQ61882084-A161D038-E868-42AE-89E8-4CE197D33935Q61882086-E06CD577-0C40-40E8-B95B-56920E97F220Q61882088-0482851D-E298-4F55-86DE-F5A0BD7E9C72Q61882095-310623C2-40AE-4E9E-8043-D9D77A542B05Q61882099-11DE2A2B-092B-4C2A-AB09-B1466C3AD55CQ61882100-88E5A0EB-8503-4848-A747-D763021ABA4D
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Silke Appel
@ast
Silke Appel
@en
Silke Appel
@es
Silke Appel
@nl
Silke Appel
@sl
type
label
Silke Appel
@ast
Silke Appel
@en
Silke Appel
@es
Silke Appel
@nl
Silke Appel
@sl
prefLabel
Silke Appel
@ast
Silke Appel
@en
Silke Appel
@es
Silke Appel
@nl
Silke Appel
@sl
P106
P21
P31
P496
0000-0002-2199-2315